Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
SAB Biotherapeutics, Inc. - Common Stock
(NQ:
SABS
)
3.950
+0.150 (+3.95%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 21, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about SAB Biotherapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
Next >
Why Nauticus Robotics Shares Are Trading Higher By 96%; Here Are 67 Biggest Movers From Yesterday
↗
October 06, 2022
Gainers Chardan NexTech Acquisition 2 Corp. (NASDAQ: CNTQ) shares surged 102.6% to close at $21.54 on Wednesday.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
October 05, 2022
Gainers
Via
Benzinga
SAB Biotherapeutics Unveils New Data From COVID-19 Programs Reinforcing Efficacy Against Variants
↗
September 28, 2022
Via
Benzinga
SAB Biotherapeutics Shifts Focus On Infection Candidate As DoD Contract Closes
↗
August 10, 2022
Via
Benzinga
Why Sotera Health Shares Are Trading Lower By Around 13%, Here Are 38 Stocks Moving In Wednesday's Mid-Day Session
↗
October 05, 2022
Gainers Pineapple Energy Inc. (NASDAQ: PEGY) shares jumped 104% to $2.9201. Shares of this low-float penny stock closed up about 80% on Tuesday.
Via
Benzinga
11 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
October 05, 2022
Gainers Bionano Genomics (NASDAQ:BNGO) stock increased by 9.8% to $2.24. The company's market cap stands at $649.9 million.
Via
Benzinga
SAB Biotherapeutics Unveils New Data at ISIRV OPTIONS XI Conference Validating SAB-176 Proof of Concept in Reducing Viral Load and Improving Symptoms of Influenza and Showing SAB-185 Effective Against Multiple COVID-19 Variants Including Omicron
September 28, 2022
SAB’s fully-human polyclonal antibody platform maintains its efficacy against multiple variants of several highly mutating viruses
From
SAB Biotherapeutics, Inc.
Via
GlobeNewswire
Why ZW Data Action Technologies Jumped 37%; Here Are 71 Biggest Movers From Yesterday
↗
September 16, 2022
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
September 15, 2022
Via
Benzinga
SAB Biotherapeutics And 1 Other Stock Under $1 Insiders Are Aggressively Buying
↗
September 15, 2022
The Nasdaq 100 gained by more than 100 points on Wednesday. Investors, meanwhile, focused on some notable insider trades.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
August 31, 2022
Via
Benzinga
Biotech Daily: Cancer Causing Impurities In Merck's Diabetic Drug, Vir Bio-GSK Shun FDA Submission Plans For COVID-19 Treatment, Aethlon's Monkeypox Trial
↗
August 10, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
June 06, 2022
Via
Benzinga
Carnival Surges Over 12%, Here's 75 Biggest Movers From Friday
↗
June 27, 2022
Gainers USA Truck, Inc. (NASDAQ: USAK) shares climbed 112.6% to close at $31.00 on Friday. DB Schenker and USA Truck announced plans to combine and create premier North American transportation...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
April 05, 2022
Gainers Sunshine Biopharma (NASDAQ:SBFM) shares rose 141.5% to $5.46 during Tuesday's regular session. Trading volume for this security as of 13:30 EST is 114.7...
Via
Benzinga
51 Biggest Movers From Yesterday
↗
April 06, 2022
Gainers Sunshine Biopharma, Inc. (NASDAQ: SBFM) shares surged 148.2% to close at $5.61 on Tuesday after the company announced that two of its designed mRNA molecules are...
Via
Benzinga
30 Stocks Moving In Tuesday's Mid-Day Session
↗
April 05, 2022
Gainers Sunshine Biopharma, Inc. (NASDAQ: SBFM) shares jumped 139% to $5.40 after the company announced that two of its designed mRNA molecules are effective at destroying...
Via
Benzinga
53 Biggest Movers From Yesterday
↗
April 01, 2022
Gainers Longeveron Inc. (NASDAQ: LGVN) shares jumped 105.4% to close at $13.80 on Thursday after the company announced the publication of results from a Phase 1 trial testing...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
March 31, 2022
Gainers Longeveron (NASDAQ:LGVN) stock rose 60.6% to $10.79 during Thursday's regular session. As of 13:31 EST, this security is trading at a volume of 84.1 million...
Via
Benzinga
36 Stocks Moving In Thursday's Mid-Day Session
↗
March 31, 2022
Gainers Longeveron Inc. (NASDAQ: LGVN) shares climbed 71% to $11.57 after the company announced the publication of results from a Phase 1 trial testing Lomecel-B on patients with...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
March 24, 2022
Gainers
Via
Benzinga
The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg
↗
March 06, 2022
Biotech stocks reversed course in the week ending March 4, as the Ukrainian crisis weighed down on the broader market as well as the sector. The iShares Biotechnology ETF (...
Via
Benzinga
Mid-Afternoon Market Update: Dow Gains 2%; SAB Biotherapeutics Shares Slide
↗
March 02, 2022
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining 2% on Wednesday. The Dow traded up 2.07% to 33,983.50 while the NASDAQ rose 1.77% to 13,771.67. The...
Via
Benzinga
68 Biggest Movers From Yesterday
↗
March 03, 2022
Gainers ECMOHO Limited (NASDAQ: MOHO) climbed 56.7% to close at $0.3650 on Wednesday after jumping 10% on Tuesday. Imperial Petroleum Inc. (NASDAQ: IMPP) shares jumped 39.2% to...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
March 02, 2022
Gainers Trevi Therapeutics (NASDAQ:TRVI) shares rose 46.6% to $1.28 during Wednesday's regular session. As of 12:30 EST, Trevi Therapeutics's stock is trading at a...
Via
Benzinga
41 Stocks Moving In Wednesday's Mid-Day Session
↗
March 02, 2022
Gainers ECMOHO Limited (NASDAQ: MOHO) jumped 67% to $0.3890 after jumping 10% on Tuesday. Nordstrom, Inc. (NYSE: JWN) shares jumped 38.7% to $27.11 after the company reported...
Via
Benzinga
Mid-Day Market Update: Nasdaq Surges 150 Points; US Crude Oil Inventories Fall By 2.6M Barrels
↗
March 02, 2022
U.S. stocks extended gains midway through trading, with the Nasdaq index jumping 150 points on Wednesday. The Dow traded up 1.71% to 33,865.43 while the NASDAQ rose 1.11% to 13,...
Via
Benzinga
Mid-Morning Market Update: U.S. Stocks Mixed; Dollar Tree Reports Mixed Q4 Results
↗
March 02, 2022
U.S. stocks opened mixed this morning, with the Dow Jones adding more than 200 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.66% to 33,513.04...
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
↗
March 02, 2022
Wednesday's session saw 107 companies set new 52-week lows. Points of Interest From Today's 52-Week Lows: Citigroup (NYSE:C) was the largest company by...
Via
Benzinga
NIH Discontinues COVID-19 Phase 3 Trial Assessing SAB Biotherapeutics' SAB-185
↗
March 02, 2022
SAB Biotherapeutics Inc (NASDAQ: SABS) said that due to low hospitalization and death rates in the trial, the National Institutes of Health's (NIH) ACTIV-2 Program is...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today